A 60-year-old man presents with a non-ST-elevation myocardial infarction and undergoes successful percutaneous coronary intervention with a drug-eluting stent. He has no major bleeding history. Which antiplatelet strategy is most consistent with Canadian guideline recommendations after discharge?